Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023)
Amarin Corp Plcuk (AMRN) posted quarterly Long-Term Investments of $100000.0 for Q2 2023, down 99.12% YoY from $11.4 million in Q2 2022, and down 81.62% sequentially from $544000.0 in Q1 2023.
Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023) Analysis & Trends
Amarin Corp Plcuk has disclosed Long-Term Investments across 4 years of filings, most recently posting $100000.0 for Q2 2023.
- In Q2 2023, Long-Term Investments fell 99.12% year-over-year to $100000.0; the TTM figure through Jun 2023 stood at $100000.0 (down 99.12% YoY), while the FY2022 annual figure was $1.3 million, down 96.36% from the prior year.
- Long-Term Investments retreated to $100000.0 in Q2 2023, from $544000.0 in the prior quarter.
- Over the last five years, Long-Term Investments for AMRN reached as high as $81.5 million in Q1 2020 and fell as low as $100000.0 in Q2 2023.
- The 4-year median for Long-Term Investments is $25.4 million (2021), against an average of $29.0 million.
- Annual changes were most pronounced in 2022 — Long-Term Investments rose 11.24% — and 2023, when it plunged 99.12%.
- A 4-year view of Long-Term Investments shows it stood at $62.5 million in 2020, then tumbled by 43.98% to $35.0 million in 2021, then slumped by 96.36% to $1.3 million in 2022, then slumped by 92.16% to $100000.0 in 2023.
- According to Business Quant data, Long-Term Investments over the past three periods registered $100000.0, $544000.0, and $1.3 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.12 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 268.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -12.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 983.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 1.63 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -24.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 26.70 Mn |
| Dec 31, 2021 | 35.00 Mn |
| Sep 30, 2021 | 38.80 Mn |
| Jun 30, 2021 | 14.16 Mn |
| Mar 31, 2021 | 24.00 Mn |
| Dec 31, 2020 | 62.47 Mn |
| Sep 30, 2020 | 46.09 Mn |
| Jun 30, 2020 | 61.04 Mn |
| Mar 31, 2020 | 81.50 Mn |